AusMedtech 2021: best value registration available for few more days

As plans are being finalised for the medtech week of the year, early bird registrations are still open until 3 April for AusMedtech 2021.

Australia’s premier medtech conference, which will be delivered virtually during 17 – 21 May 2021, has been timed to be inclusive of states around the country to make this a truly national event, including Western Australia.

AusMedtech 2021: Reimagine and reconnect provides an opportunity for the whole Australian medtech community to unite through an accessible week of virtual half-day sessions. Reconnect with a network of resilient and innovative leaders and reimagine the future of medtech beyond our borders.

AusBiotech’s premier medtech conference brings together key stakeholders of the Australian and international medical devices and diagnostics sector to help prepare the industry sector for its changing landscape. More than 350 delegates are expected to attend the event that is run by industry, for industry.

An inspiring line-up of Australian and global keynotes and panels has been announced, including keynote speakers Dr Sean Parsons, Founder and Chief Executive Officer, who will share insights on Ellume, the Australian success story; and Kate Quirke, Managing Director and Chief Executive, who will present on how Alcidion’s built their business through accessing the global market.

The five days will traverse the medtech pipeline, with themes across the week including:

· Product development, idea generation, feasibility prototyping and manufacturing

· Regulation, clinical trials and reimbursement

· Investment, investor relations, partnering and grants

· Marketing, distribution and partnering for market access

· Early Stage Investment Forum.

AusMedtech 2021 is supported by the Victorian Government as the Host State Partner.

Early bird registrations are available until 3 April; register now to connect with like-minded leaders growing the Australian and global medtech industry.

/Public Release. This material comes from the originating organization and may be of a point-in-time nature, edited for clarity, style and length. View in full here.